Skip to main content

MoneyWorks4Me

The turnover soared 52.63% to Rs. 5800.00 millions for the September 2026 quarter as compared to Rs. 3800.00 millions during the corresponding quarter last year.Profit for the quarter ended September 2026 rises by 85.19% to Rs. 1000.00  millions from Rs. 540.00 millions.OP of the company witnessed a marginal growth to 1950.00 millions from 1430.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 5800.00 3800.00 52.63 11410.00 7930.00 43.88 17390.00 14020.00 24.04
Other Income 210.00 300.00 -30.00 540.00 550.00 -1.82 1370.00 550.00 149.09
PBIDT 1950.00 1430.00 36.36 3860.00 2990.00 29.10 6540.00 3550.00 84.23
Interest 480.00 440.00 9.09 910.00 850.00 7.06 1760.00 1990.00 -11.56
PBDT 1470.00 990.00 48.48 2950.00 2140.00 37.85 5030.00 1560.00 222.44
Depreciation 470.00 450.00 4.44 880.00 910.00 -3.30 1860.00 1680.00 10.71
PBT 1000.00 540.00 85.19 2070.00 1230.00 68.29 3170.00 -120.00 -2741.67
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1000.00 540.00 85.19 2070.00 1230.00 68.29 3170.00 -120.00 -2741.67
Equity 810.00 810.00 0.00 810.00 810.00 0.00 810.00 810.00 0.00
PBIDTM(%) 33.62 37.63 -10.66 33.83 37.70 -10.28 37.61 25.32 48.52
Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..